Explore strategies for controlling COPD and improving health, with a focus on management and lifestyle changes.

Asthma–chronic obstructive pulmonary disease (COPD ... trials to evaluate specific drug interventions on important outcomes such as lung function, acute exacerbations, quality of life and ...

Centre, a national research platform led by Nanyang Technological University, Singapore's (NTU Singapore) Lee Kong Chian School of Medicine (LKCMedicine), will lead a multi-institutional research ...

The drug provides both bronchodilation ... could also be heading for approval in COPD – at the second attempt – after reducing exacerbations in the phase 3 MATINEE trial, while Amgen and ...

Verona Pharma stock hit a record high Thursday on continued enthusiasm for its newly launched COPD treatment, Ohtuvayre.

Sinead O'Connor's cause of death has been revealed, as well as the contents of her will, in which she asked her children to ...

New drugs for COPD are currently being studied ... such as patients with sputum eosinophilia or with a high rate of exacerbations. Despite the poor advances in the pharmacologic therapy, other ...

Analysts see the drug achieving blockbuster status quickly ... therapy lowered the rate of moderate or severe exacerbations among COPD patients. Amgen and AstraZeneca have hopes for their asthma ...

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

The drug remains one of GSK's top products ... Elevated eosinophil levels are associated with more severe COPD and a higher rate of exacerbations, the sudden flare-ups in symptoms that signal ...

Paul Hudson - Chief Executive Officer Francois-Xavier Roger - Chief Financial Officer Houman Ashrafian - Executive Vice President and Head of Research and Development ...